Glenmark, Merck ink euro 190mn drug deal |
Our Web Bureau / Mumbai October 17, 2006 |
Glenmark Pharmaceuticals S.A., the Switzerland-based subsidiary of Glenmark, and Merck KGaA have entered into an agreement under which Merck KGaA will develop, register and commercialize Glenmark |